Vermillion, inc. (VRML)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Revenue:
Product

-

-

-

2,320

1,861

2,067

2,112

1,640

1,469

308

Service

-

-

-

322

0

-

-

-

-

-

License

-

-

-

-

316

454

454

454

454

867

Revenue

4,538

3,053

3,121

2,642

2,177

2,521

2,566

2,094

1,923

1,175

Cost of revenue:
Product

-

-

-

1,974

2,309

1,230

170

131

129

88

Service

-

-

-

724

0

-

-

-

-

-

Cost of revenue

3,343

3,142

2,914

2,698

2,309

-

-

131

129

88

Gross profit

1,195

-89

207

-56

-132

1,291

2,396

1,963

1,794

1,087

Operating expenses:
Research and development

1,018

550

837

2,172

3,751

4,667

2,595

2,216

5,387

3,848

Sales and marketing

9,645

5,642

4,268

6,798

9,833

9,893

4,480

4,653

5,539

2,857

General and administrative

5,810

5,052

5,543

5,928

5,533

5,942

4,184

4,508

8,509

8,984

Total operating expenses

16,473

11,244

10,648

14,898

19,117

20,502

11,259

11,377

19,435

15,689

Loss from operations

-15,278

-11,333

-10,441

-14,954

-19,249

-19,211

-8,863

-9,414

-17,641

-14,602

Interest income, net

59

-22

-42

-28

28

-

-

-

-

-

Other income (expense), net

-18

-16

-14

14

-

-

-

-

-

-

Interest income

-

-

-

-

-

40

-

-

64

40

Interest income

-

-

-

-

-

-

23

28

-

-

Interest expense

-

-

-

-

-

-

-

206

396

491

Gain on sale of instrument business

-

-

-

-

-

-

-

1,830

-

-

Gain on litigation settlement, net

-

-

-

-

-

-

-

710

-

-

Gain on investments in auction rate securities

-

-

-

-

-

-

-

-

-

58

Change in fair value of warrants

-

-

-

-

-

-

-

-

378

-4,353

Debt conversion costs

-

-

-

-

-

-

-

-

-

141

Reorganization items

-

-

-

-

-

-

-

-88

96

1,677

Reorganization items - related party incentive plan

-

-

-

-

-

-

-

-

-

6,932

Other income (expense), net

-

-

-

-

106

-38

21

-182

-99

358

Loss before income taxes

-

-

-

-

-

-19,209

-8,819

-7,146

-17,790

-19,034

Income tax benefit (expense)

-

-

-

-

-

0

0

-

0

0

Net loss

-15,237

-11,371

-10,497

-14,968

-19,115

-19,209

-8,819

-7,146

-17,790

-19,034

Deemed dividend on warrant repricing

-

-

942

0

-

-

-

-

-

-

Net loss attributable to common stockholders

-

-

-11,439

-14,968

-

-

-

-

-

-

Net loss per share - basic and diluted

-0.18

-0.16

-0.20

-0.29

-0.41

-0.53

-0.42

-0.48

-1.25

-1.83

Weighted average common shares used to compute basic and diluted net loss per common share

86,595

70,085

56,943

52,197

47,124

36,082

20,926

15,010

14,249

10,404

Net loss

-15,237

-11,371

-10,497

-14,968

-

-

-8,819

-7,146

-17,790

-19,034

Foreign currency translation adjustment

-

-

-

-

-

-

-

153

3

-

Comprehensive loss

-

-

-

-

-

-

-

-6,993

-17,787

-

Product [Member]
Revenue

4,404

2,772

2,853

-

-

-

-

-

-

-

Cost of revenue

2,378

2,044

1,756

-

-

-

-

-

-

-

Genetics [Member]
Revenue

22

-

-

-

-

-

-

-

-

-

Cost of revenue

295

-

-

-

-

-

-

-

-

-

Service [Member]
Revenue

112

281

268

-

-

-

-

-

-

-

Cost of revenue

670

1,098

1,158

-

-

-

-

-

-

-